The Phaserl


FDA to Approve Cannabis-Based Pharmaceutical for Multiple Health Conditions

by Christina Sarich, Natural Society:

GW Pharmaceuticals is expected to be given a green light for a cannabidiol drug (marijuana-based medicine) which has shown promise in the treatment of epileptic children, cutting epileptic attacks down by as much as 100% (45% average). When will the Feds admit cannabis is a medical miracle?

In one breath the mainstream medical system has been telling us that ‘cannabis has no medicinal value,’ while the U.S. government has stealthily patented cannabinoid-based medicine which obviously shows that our government officials are well aware that cannabis can be extremely valuable from a medicinal standpoint.

The FDA will soon grant a license to GW Pharmaceuticals for treating patients with multiple sclerosis with a drug called Epidiolex. That’s odd, since the FDA has repeatedly said that marijuana is not ‘safe and effective’ for treating anything. [1]

Similar cannabis-based formulations created by GW Pharmaceuticals and other drug companies are expected to treat autism, muscular dystrophy, glioma, ovarian and pancreatic cancer and schizophrenia, as well as epileptics. Orders for this product are expected to grow 40 times over in the coming years. [2]

Obtained in 2003, one U.S. government patent (US Patent 6630507) titled “Cannabinoids as antioxidants and neuroprotectants” is assigned to The United States of America, as represented by the Department of Health and Human Services. The patent states:

Read More @

Help us spread the ANTIDOTE to corporate propaganda.

Please follow SGT Report on Twitter & help share the message.

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>